Pemphigus Vulgaris
Symptoms, Doctors, Treatments, Advances & More

Learn About Pemphigus Vulgaris

What is the definition of Pemphigus Vulgaris?

Pemphigus vulgaris (PV) is an autoimmune disorder of the skin. It involves blistering and sores (erosions) of the skin and mucous membranes.

What are the alternative names for Pemphigus Vulgaris?

PV

What are the causes of Pemphigus Vulgaris?

The immune system produces antibodies against specific proteins in the skin and mucous membranes. These antibodies break the bonds between skin cells. This leads to the formation of a blister. The exact cause is unknown.

In rare cases, PV is caused by some medicines, including:

  • A medicine called penicillamine, which removes certain materials from the blood (chelating agent)
  • Blood pressure medicines called ACE inhibitors
  • Nonsteroidal anti-inflammatory drugs (NSAIDs)

PV is uncommon. It most often occurs in middle-aged or older people.

What are the symptoms of Pemphigus Vulgaris?

About 50% to 70% of people with this condition first develop painful blisters and sores in the mouth. This is followed by skin blisters. Skin sores may come and go.

The skin sores may be described as:

  • Draining
  • Oozing
  • Crusting
  • Peeling or easily detached

They may be located:

  • In the mouth and down the throat
  • On the face or in the eyes
  • On the scalp, trunk, or other skin areas
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Pemphigus Vulgaris?

Severe cases of PV may need wound management, similar to the treatment for severe burns. People with PV may need to stay in a hospital and receive care in a burn unit or intensive care unit.

Treatment is aimed at reducing symptoms, including pain. It also aims to prevent complications, especially infections.

Treatment may involve:

  • Antibiotics and antifungal medicines to control or prevent infections
  • Fluids and electrolytes given through a vein (IV) if there are severe mouth ulcers
  • IV feedings if there are severe mouth ulcers
  • Numbing (anesthetic) mouth lozenges to reduce mouth ulcer pain
  • Pain medicines if local pain relief is not enough

Body-wide (systemic) therapy is needed to control PV and should be started as early as possible. Systemic treatment includes:

  • Medicines that suppress the immune system. These are often first-line treatments (such as rituximab, azathioprine, methotrexate, cyclosporine, cyclophosphamide, or mycophenolate mofetil).
  • An anti-inflammatory medicine called dapsone.
  • Corticosteroids.
  • Medicines containing gold (rarely used now).

Intravenous immunoglobulin (IVIg) is occasionally used.

Plasmapheresis may be used along with systemic medicines to reduce the amount of antibodies in the blood. Plasmapheresis is a process in which antibody-containing plasma is removed from the blood and replaced with intravenous fluids or donated plasma.

Ulcer and blister treatments include soothing or drying lotions, wet dressings, or similar measures.

Who are the top Pemphigus Vulgaris Local Doctors?
Elite in Pemphigus Vulgaris
Elite in Pemphigus Vulgaris
Referral may be required

UCI Health Dermatology Center

850 Health Sciences Road, Floor 2, 
Irvine, CA 
Languages Spoken:
English, Russian
Accepting New Patients
Offers Telehealth

Sergei Grando is a Dermatologist practicing medicine in Irvine, California. Dr. Grando is rated as an Elite provider by MediFind in the treatment of Pemphigus Vulgaris. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pemphigus Vulgaris, Pemphigus, Pemphigus Foliaceus, and Bullous Pemphigoid. Dr. Grando is board certified in American Board Of Dermatology - Dermatology. Dr. Grando is currently accepting new patients.

Elite in Pemphigus Vulgaris
Dermatology
Elite in Pemphigus Vulgaris
Dermatology
Referral required

Emory Clinic At 1525 Clifton Road

1525 Clifton Road Northeast, Fl3, 
Atlanta, GA 
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Ron Feldman is a Dermatologist practicing medicine in Atlanta, Georgia. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Pemphigus Vulgaris. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Bullous Pemphigoid, Pemphigus Foliaceus, Pemphigus, and Pemphigus Vulgaris. Dr. Feldman is board certified in American Board Of Dermatology, 2010. Dr. Feldman is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Pemphigus Vulgaris
Dermatology
Elite in Pemphigus Vulgaris
Dermatology
Referral may be required

Rush University Medical Center

1725 W Harrison St Ste 264, 
Chicago, IL 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Kyle Amber is a Dermatologist practicing medicine in Chicago, Illinois. Dr. Amber is rated as an Elite provider by MediFind in the treatment of Pemphigus Vulgaris. He is also highly rated in 91 other conditions, according to our data. His clinical expertise encompasses Bullous Pemphigoid, Pemphigus, Pemphigus Vulgaris, and Cicatricial Pemphigoid. Dr. Amber is currently accepting new patients.

What is the outlook (prognosis) for Pemphigus Vulgaris?

Without treatment, this condition can be life threatening. Severe infection is the most frequent cause of death.

With treatment, the disorder tends to be chronic. Side effects of treatment may be severe or disabling.

What are the possible complications of Pemphigus Vulgaris?

Complications of PV include:

  • Secondary skin infections
  • Severe dehydration
  • Side effects of medicines
  • Spread of infection through the bloodstream (sepsis)
When should I contact a medical professional for Pemphigus Vulgaris?

Your health care provider should examine any unexplained blisters.

Contact your provider if you have been treated for PV and you develop any of the following symptoms:

  • Chills
  • Fever
  • General ill feeling
  • Joint aches
  • Muscle aches
  • New blisters or ulcers
What are the latest Pemphigus Vulgaris Clinical Trials?
A Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CD19 CAR-T Cell Therapy in Patients With Moderate-to-Severe Refractory Pemphigus Vulgaris

Summary: This is an investigator-initiated, single-center, single-arm, open-label exploratory clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of autologous CD19 CAR-T cell therapy in patients with refractory pemphigus vulgaris.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Evaluation of the Effectiveness of Clobetasol Propionate 0.05% and Photobiomodulation in the Management of Oral Lesions in Patients With Pemphigus Vulgaris. (Three-arm Randomized Controlled Clinical Study)

Summary: Pemphigus vulgaris (PV) is a chronic, potentially life-threatening autoimmune mucocutaneous disorder that significantly impairs patients' quality of life. While systemic corticosteroids and immunosuppressants remain the standard of care, many patients suffer from persistent, painful oral lesions that exhibit delayed healing or poor response to conventional systemic protocols. This clinical trial i...

Who are the sources who wrote this article ?

Published Date: April 09, 2026
Published By: Elika Hoss, MD, Assistant Professor of Dermatology, Mayo Clinic, Scottsdale, AZ. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Amagai M. Pemphigus. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 5th ed. Philadelphia, PA: Elsevier; 2025:chap 29.

Dinulos JGH. Vesicular and bullous diseases. In: Dinulos JGH, ed. Habif's Clinical Dermatology. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 16.

James WD. Chronic blistering dermatoses. In: James WD, ed. Andrew's Diseases of the Skin: Clinical Dermatology. 14th ed. Philadelphia, PA: Elsevier; 2026:chap 16.